Apoptosis, clearance mechanisms, and the development of systemic lupus erythematosus.

被引:34
|
作者
Navratil J.S. [1 ]
Ahearn J.M. [1 ]
机构
[1] University of Pittsburgh School of Medicine, University of Pittsburgh Arthritis Institute, S705 Biomedical Science Tower, 3500 Terrace Street, Pittsburgh, 15261, PA
关键词
Systemic Lupus Erythematosus; Apoptotic Cell; Immune Tolerance; Classical Pathway; Congenital Heart Block;
D O I
10.1007/s11926-001-0018-1
中图分类号
学科分类号
摘要
Cell death by apoptosis is an integral part of many biologic processes, including embryonic development, T- and B-cell selection, the elimination of potentially autoreactive lymphocytes in the periphery, and maintenance of lymphocyte homeostasis through activation-induced cell death. There is also increasing evidence that apoptosis may maintain immune tolerance and that it may be the process that generates the self antigens responsible for the initial development of autoimmunity. This review discusses some of the biochemical steps involved in the apoptotic process, how potentially immunogenic self antigens are generated during apoptosis, and the mechanisms by which the products of apoptosis are cleared and processed to avoid breaking immune tolerance.
引用
收藏
页码:191 / 198
页数:7
相关论文
共 50 条
  • [21] Clinical trials in systemic lupus erythematosus.
    Buyon J.P.
    Current Rheumatology Reports, 2000, 2 (1) : 11 - 12
  • [22] Late onset systemic lupus erythematosus.
    Boddaert, J
    Huong, DLT
    Amoura, Z
    Wechsler, B
    Godeau, P
    Piette, JC
    ARTHRITIS AND RHEUMATISM, 2003, 48 (09): : S583 - S583
  • [23] Tuberculosis in patients with systemic lupus erythematosus.
    Kim, CH
    Do, JH
    Ko, HJ
    Jung, YO
    Min, DJ
    Kim, WU
    Lee, SH
    Cho, CS
    Kim, HY
    ARTHRITIS AND RHEUMATISM, 2002, 46 (09): : S60 - S60
  • [24] Response to aspirin in systemic lupus erythematosus.
    Avalos, I
    Chung, CP
    Oeser, A
    Morrow, JD
    Stein, CM
    ARTHRITIS AND RHEUMATISM, 2005, 52 (09): : S602 - S603
  • [25] Cigarette smoking: A major risk for the development of systemic lupus erythematosus.
    Ghaussy, NO
    Qualls, C
    Sibbitt, WL
    JOURNAL OF INVESTIGATIVE MEDICINE, 2000, 48 (01) : 72A - 72A
  • [26] Predictors of survival in systemic lupus erythematosus.
    Kasitanon, N
    Magder, L
    Petri, M
    ARTHRITIS AND RHEUMATISM, 2005, 52 (09): : S186 - S186
  • [27] Immunosuppressive treatment of systemic lupus erythematosus.
    Euler, HH
    Schroeder, JO
    NIEREN-UND HOCHDRUCKKRANKHEITEN, 1995, 24 (12) : 686 - 696
  • [28] Metabolic Underpinnings of Systemic Lupus Erythematosus.
    Wu, Tianfu
    Xie, Chun
    Han, Jie
    Blanco, Irene
    Olsen, Nancy J.
    Putterman, Chaim
    Saxena, Ramesh
    Mohan, Chandra
    ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S560 - S560
  • [29] Predictors of Obesity in Systemic Lupus Erythematosus.
    Petri, Michelle
    Adusumilli, Sesha
    Fang, Hong
    ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S603 - S603
  • [30] Oral Candidiasis in Systemic Lupus Erythematosus.
    Fangtham, Monthida
    Fang, Hong
    Petri, Michelle
    ARTHRITIS AND RHEUMATISM, 2013, 65 : S248 - S248